Telix Pharmaceuticals | TLX - Current Liabilities

Stock Price
10.11
Daily Change
-0.11 -1.03%
Monthly
-10.18%
Yearly
-65.33%
Q1 Forecast
10.34

Telix Pharmaceuticals reported AUD330.91M in Current Liabilities for its fiscal semester ending in December of 2024.





Current Liabilities Change Date
Cochlear AUD 602.3M 23.8M Jun/2025
CSL USD 4.82B 1.26B Jun/2025
Integral Diagnostics AUD 85.68M 388K Jun/2024
Mayne Pharma AUD 313.94M 18.28M Jun/2024
Medical Developments International AUD 7.82M 1.45M Jun/2025
Mesoblast USD 102.63M 29.88M Jun/2025
Neuren Pharmaceuticals AUD 7.92M 37.84M Jun/2025
Pacific Edge NZD 7.22M 2.54M Dec/2025
Paradigm Biopharmaceuticals AUD 3.23M 2.15M Jun/2025
Polynovo AUD 23.25M 9.22M Jun/2024
PYC Therapeutics AUD 12.32M 939.58K Jun/2025
Ramsay Health Care AUD 4.47B 750.4M Jun/2025
ResMed USD 1.25B 7.39M Dec/2025
Sonic Healthcare AUD 2.23B 92.84M Dec/2024